Abstract:The molecular mechanism that activates invasion and metastasis of human gliomas remains obscure. Although several studies have implicated the function of LRIG1 in the inhibition of the invasion, the downstream genes coordinating this process are poorly known. Therefore, we prepared a full-length expression vector to overexpress LRIG1 in the U251 malignant glioma cell line and simultaneously we used small interfering RNA (siRNA) to block LRIG1 gene in the U251 malignant glioma cell line. Introduction of exogenous LRIG1 into glioma cells inhibited cell invasion and metastasis. Silencing of LRIG1 promoted cell invasion and metastasis as manifested by transwell assay, and transwell migration assay in vitro. On the other hand, with qRT-PCR and western blot, LRIG1 overexpression inhibited cell invasion and metastasis, leading to, leading to reduced SNAI2 expression and elevated Elevated E-cadherin expression. By contrast, knockdown of endogenous LRIG1 promoted cell invasion and metastasis, leading to, leading to reduced E-cadherin expression and elevated Elevated SNAI2 expression. Our data suggested that LRIG1 as a tumor suppressor restricted glioma invasion and metastasis by regulating SNAI2 and SNAI2 levels. Restoration of LRIG1 in glioma cells could be a novel therapeutic strategy.

LRIG 1-modulated invasion and metastasis of human gliomas through regulation of SNAI 2 and E-cadherin